Jove
Visualize
Contact Us

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

435
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
435
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

482
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
482
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

879
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
879
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.7K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

803
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
803
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

1.0K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulmonary Arterial Hypertension With a Secundum Atrial Septal Defect: "Treat-and-Repair" Strategy.

JACC. Case reports·2026
Same author

Reverse Crush Versus Culotte in Bifurcation Lesions After Provisional Stenting: Insights From the PROGRESS-BIFURCATION Registry.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Does Height Influence the Effectiveness of Beta-Blocker Therapy after Myocardial Infarction?

Cardiology·2026
Same author

Impact of Adherence to the Global Algorithm for Initial Crossing Strategy Selection in Chronic Total Occlusion Percutaneous Coronary Intervention.

The American journal of cardiology·2026
Same author

AI-Enhanced Electrocardiogram for Detection of Occlusive Myocardial Infarction in High-Risk Non-ST-Segment Elevation Acute Coronary Syndrome.

JACC. Advances·2026
Same author

Perioperative outcomes of robotic versus conventional minimally invasive McKeown esophagectomy for esophageal cancer: An updated systematic review and meta-analysis.

Journal of robotic surgery·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 17, 2026

Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.4K

Hybrid coronary revascularization: present indications and future perspective.

Konstantinos Voudris1, Dimitrios V Avgerinos, Dmitriy Feldman

  • 1New York-Presbyterian Hospital, Greenberg Division of Cardiology, Weill Medical College of Cornell University, New York, NY, 10021, USA.

Current Treatment Options in Cardiovascular Medicine
|February 25, 2015
PubMed
Summary

Hybrid coronary revascularization (HCR) offers a safe and effective approach for high-risk patients with multivessel coronary artery disease. This strategy combines minimally invasive bypass grafting with stenting, showing promising outcomes and shorter hospital stays.

More Related Videos

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

1.3K
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

6.0K

Related Experiment Videos

Last Updated: Apr 17, 2026

Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.4K
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

1.3K
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

6.0K

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology

Background:

  • Hybrid coronary revascularization (HCR) integrates left internal mammary artery (LIMA) bypass grafting to the left anterior descending (LAD) artery with percutaneous coronary intervention (PCI) for other lesions.
  • This strategy leverages the benefits of LIMA-LAD grafts and drug-eluting stents (DES) for non-LAD regions.
  • HCR is typically reserved for high-risk patients with specific coronary anatomy.

Purpose of the Study:

  • To evaluate the safety and efficacy of the HCR strategy.
  • To assess outcomes such as mortality, morbidity, and resource utilization in patients undergoing HCR.

Main Methods:

  • Review of small, non-randomized studies examining HCR outcomes.
  • Comparison of HCR with conventional coronary artery bypass grafting (CABG) in selected patient populations.

Main Results:

  • HCR demonstrates low mortality and morbidity rates.
  • Patients undergoing HCR experience shorter intensive care unit and hospital stays.
  • Despite a lack of large randomized trials, existing data suggest favorable outcomes.

Conclusions:

  • HCR is a safe and promising alternative to CABG for select patients with multivessel coronary artery disease.
  • The approach appears cost-effective, offering potential benefits in terms of recovery time.
  • Further multicenter randomized trials are warranted to solidify HCR's role in treatment guidelines.